-
Product Insights
Leukodystrophies – Drugs In Development, 2023
Global Markets Direct’s, ‘Leukodystrophies - Drugs In Development, 2023’, provides an overview of the Leukodystrophies pipeline landscape. The report provides comprehensive information on the therapeutics under development for Leukodystrophies, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Metachromatic Leukodystrophy (MLD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Metachromatic leukodystrophy (MLD) is an inherited disorder characterized by the accumulation of fats called sulfatides in cells. The Metachromatic Leukodystrophy pipeline market research report provides comprehensive information on the therapeutics under development for Metachromatic Leukodystrophy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally,...
-
Track & Monitor
Pharmaceuticals Sector Partnerships, Licensing, Investments Mergers and Acquisitions Deals and Trends for April 2020
GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for April 2020 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in April 2020. The report portrays detailed comparative data on the number of deals and their value in the last...